von Tobias Borgers | Nov. 7, 2019 | Allgemein
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced new data from the randomized Phase IIIb Assessing Very Early Rheumatoid arthritis Treatment (AVERT)-2 trial exploring de-escalation of therapy in early, seropositive...
von Tobias Borgers | Nov. 6, 2019 | Allgemein
Bristol-Myers Squibb (NYSE:BMY) had its target price raised by Bank of America from $49.00 to $50.00 in a research note issued to investors on Thursday, October 10th, BenzingaRatingsTable reports. They currently have a neutral rating on the biopharmaceutical company’s...
von Tobias Borgers | Okt. 27, 2019 | Allgemein
Global Antineoplastic Drugs Market Report 2019 – 2025 Overview, Share, Revenue, Price and Gross Margin, Trend and Forecast is a professional and in-depth study on the current state of the Antineoplastic Drugs industry. The global Antineoplastic Drugs market is...
von Tobias Borgers | Okt. 16, 2019 | Allgemein
“Global Diabetes Management Market Report 2019-2025” helps the clients to take business decisions and to understand strategies of major players in the industry. The report also calls for market – driven results deriving feasibility studies for client needs....
von Tobias Borgers | Okt. 14, 2019 | Allgemein
Bristol-Myers Squibb’s top two products just keep growing, and now the company may be adding a $10 billion brand via the planned acquisition of Celgene. Bristol-Myers Squibb Co. 430 E. 29th Street, 14th FloorNew York, NY 10016Phone: 212-546-4000Website: bms.com...
von Tobias Borgers | Okt. 9, 2019 | Allgemein
New York City, NY: Oct 09, 2019 – Published via (Wired Release) – The global Blood Preparation market is comprehensively researched and analyzed in the report by MarketResearch.Biz to help out market players to improve their business plans and ensure long-term...
